ClinicalTrials HQ

Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia

Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia

Recruiting · NCT06597019 · Registry updated 2026-05-15
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial HypercholesterolemiaCongenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Hypercholesterolemia, Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors, Nutritional and Metabolic Diseases, Ventricular Outflow Obstruction, aortic valve disorder, aortic valve stenosis, cardiovascular disorder, familial hypercholesterolemia, heart disorder, heart failure, heart valve disorder, hereditary disease, hyperlipidemia, hyperlipoproteinemia, inborn errors of metabolism, metabolic diseaseRecruitingPhase 32026-05-15NCT06597019

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Novartis Pharmaceuticals432

9 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Children's National HospitalWashington D.C.United States100
Childrens National HospitalWashington D.C.United States10
Excel Medical Clinical Trials LLCBoca RatonUnited States9
Icahn School of Med at Mt SinaiNew YorkUnited States6
Primary Childrens Medical CenterSalt Lake CityUnited States3
UC San Francisco Medical CenterSan FranciscoUnited States3
UC San Francisco Medical CenterSan FranciscoUnited States2
Virginia Commonwealth UniversityRichmondUnited States156
West Virginia Childrens HospitalMorgantownUnited States1